Robert C. Goeltz II
2015 - CytomX Therapeutics
In 2015, Robert C. Goeltz II earned a total compensation of $2.5M as Chief Financial Officer and Secretary at CytomX Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $114,095 |
|---|---|
| Option Awards | $2,154,376 |
| Salary | $197,503 |
| Other | $315 |
| Total | $2,466,289 |
Goeltz received $2.2M in option awards, accounting for 87% of the total pay in 2015.
Goeltz also received $114.1K in non-equity incentive plan, $197.5K in salary and $315 in other compensation.
Rankings
In 2015, Robert C. Goeltz II's compensation ranked 3,887th out of 13,638 executives tracked by ExecPay. In other words, Goeltz earned more than 71.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,887 out of 13,638 | 72nd |
Division Manufacturing | 1,415 out of 5,190 | 73rd |
Major group Chemicals And Allied Products | 514 out of 1,854 | 72nd |
Industry group Drugs | 408 out of 1,528 | 73rd |
Industry Pharmaceutical Preparations | 322 out of 1,182 | 73rd |
Source: SEC filing on May 9, 2017.
Goeltz's colleagues
We found three more compensation records of executives who worked with Robert C. Goeltz II at CytomX Therapeutics in 2015.